Pharma Talks

In Part 2 of this Pharma Talks conversation, Nataliya Andreychuk and Richard Schwartz continue their discussion about why experience is medicine — and explore what technology, data, and AI could mean for the future of healthcare experiences.From rethinking brand websites and using AI to understand the questions patients are really asking, to challenging pharma's approach to HCP engagement, patient support, and measurement, Richard argues that the industry has an opportunity to create experiences that are as sophisticated as the science behind the medicines.The conversation also explores the potential of agentic AI in healthcare — from helping with prior authorization and prescription access to coordinating delivery and patient education — and why making this future possible will require greater cooperation across the healthcare ecosystem. 00:00 AI & the future of healthcare experience02:27 From search to questions 04:28 Hot or Not: fewer, better communications07:00 Data-rich, value-poor?11:34 Rethinking patient support15:37 Measuring what matters 21:12 Real-time experience & agentic AI24:00 How to make experience part of the plan📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk 🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Richard Schwartz → https://www.linkedin.com/in/richardpschwartz/

What happens between a pharmaceutical product and the patient who needs it?In Part 1 of this Pharma Talks conversation, Nataliya Andreychuk sits down with Richard Schwartz, a healthcare and pharmaceutical industry expert with three decades of experience across pharma, consulting, agencies, publishing and technology, to explore one of the industry's biggest blind spots: the experience surrounding the medicine.The conversation goes deeper into trust in pharma, patient-centricity, healthcare customer experience, patient support programs and why experience should be treated as part of the product — not an extra layer added after the medicine is developed.00:00 Experience as a medicine03:20 Trust: the metric pharma can't ignore10:12 The "Healthcare Pea Soup"14:11 Design the experience from day one18:52 AI, empathy & the human advantage26:55 The rise of digital opinion leaders📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Richard Schwartz → https://www.linkedin.com/in/richardpschwartz/

In this solo episode of Pharma Talks, Nataliya Andreychuk takes an unfiltered look at one of the biggest challenges emerging from AI adoption in the pharmaceutical industry: the velocity trap.Pharma is investing billions in artificial intelligence, accelerating content production, expanding into new channels, and making localization easier than ever. Yet at the same time, huge volumes of approved content are never used.Nataliya explores what happens when AI-powered content creation moves faster than the workflows, relationships, and human expertise needed to make that content meaningful. She looks at the gap between content production and HCP engagement, the role of AI-native pharma organizations, and why AI may be exposing — rather than solving — broken pharmaceutical content workflows.The conversation also introduces the HUMICS framework and explores the uniquely human capabilities that will become even more important in an AI-native pharmaceutical organization.00:00 Welcome to a solo episode of Pharma Talks 00:07 Pharma’s massive AI investment and the race for efficiency 02:00 The AI content “velocity trap” 04:00 Why more content doesn’t necessarily mean more engagement 06:00 AI-native pharma and the future of human expertise 08:00 The HUMICS framework 10:00 Human-in-the-loop, MLR and compliant AI 12:00 The AI roadmap pharma leaders should be building📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk.🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/

Steve Swan returns to Pharma Talks for a conversation about what has changed in pharma talent and recruitment since his last conversation with Nataliya Andreychuk a year ago.And the answer is: a lot.AI is now writing job descriptions, tailoring resumes, screening candidates — and, in some cases, essentially creating an AI-versus-AI recruitment loop. The result? Hundreds of polished applications, but not necessarily more people who can actually do the job.With nearly 30 years of experience hiring across pharma and biotech, Steve shares what he is seeing from the front lines — from the growing demand for AI talent to the rise of "AI-native" professionals and the new role of humans in an increasingly AI-driven workplace.Chapters:0:00 AI is already changing recruitment4:13 The AI recruitment loop: when AI starts checking its own homework11:37 Are AI-native professionals the next generation of pharma talent?15:05 The "bionic employee" and why human intelligence still matters19:38 Hot or Not: Is pharma already losing the AI talent race?24:32 Can pharma compete with Big Tech for AI talent?25:06 Where will the next pharma talent wave come from?📲 Enjoyed this episode?👉 Like, subscribe & hit the 🔔 to never miss a Pharma Talks episode.👉 Have a question about hiring, recruiting or building AI talent in pharma and biotech? Send it our way — we're listening.🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Steve Swan → https://www.linkedin.com/in/swangroup/

Part 2 of this Pharma Talks conversation with Elaine Gamble moves from identifying the challenges of Commercial and Medical collaboration to the practical steps organizations can take to create connected customer experiences.The discussion explores how AI, next best action, customer data, and organizational culture can help pharma teams work as one — without compromising compliance or scientific integrity. 📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode.👉 Want to be a guest? Plan your recording with Nataliya Andreychuk. 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Elaine Gamble → https://www.linkedin.com/in/elainegamble/